Download Hypoglycemia

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Hypoglycemia
Paolo Aquino
29 January 2003
Overview of hypoglycemia
 What
is it?
 Why do we care about it?
 What causes it?
 How do we diagnose it?
 What do we do about it?
 How do we prevent it?
What is it?
Strictly, hypoglycemia refers to a low level
of serum glucose
 It occurs when a mismatch of endogenous
glucose need with exogenous and
endogenous glucose availability derails the
metabolic engine of normal glucose
homeostasis
 Often defined as a plasma glucose level <
2.5-2.8 mmol/L (< 45-50 mg/dL)

Why do we care about it?
Because
hypoglycemia
can kill
Why do we care about it?
 Physiology
– Glucose is an obligate metabolic fuel for
the brain under physiologic conditions,
while other organs can use other forms
of fuel (i.e. fatty acids)
– The brain can not synthesize its own
glucose; it requires a continuous supply
via arterial blood
Why do we care about it?
 Physiology
– As the plasma glucose concentration
falls below the physiologic range, bloodto-brain glucose transport becomes
insufficient for adequate brain energy
metabolism and functioning
Why do we care about it?
 Maintenance
of glucose homeostasis
– Narrow plasma glucose range is
normally maintained despite fluctuations
in food intake and activity levels
– Maintenance through diet, glycogen
breakdown (liver) and gluconeogenesis
(liver and kidney)
Glucose metabolism
Glucose metabolism
 Glycogen
stores can last 8-12 hours
 Precursors for gluconeogenesis
coordinated amongst liver, muscle
and adipose tissue
– Muscle: lactate, pyruvate, amino acids
– Adipose: glycerol, fatty acids
Hormonal control
 Insulin-
inhibits glycogenolysis and
gluconeogenesisdecreased serum
glucose
 Glucagon- promotes glycogenolysis
and gluconeogenesis
 Epinephrine- limits utilization of
glucose by insulin-sensistive tissues
 Growth hormone and cortisol have a
role during prolonged hypoglycemia
What causes it?
 Two
major etiological classes
– Increased insulin levels
 Over-medicating
 Insulinoma
 Sepsis
– Underproduction of glucose
 Medications-
alcohol, salicylates, b-blockers
 Adrenal insufficiency
 Liver disease
 Malnutrition, dehydration
Hypoglycemia in diabetes
Whipple’s Triad
 Symptoms
of hypoglycemia
 Low plasma glucose levels
 Resolution of symptoms with
administration of glucose
Symptoms
 Adrenergic:
diaphoresis,
tachycardia, anxiety, hunger
 Neuroglycopenic:
dizziness,
confusion, slurred speech, seizure
Diagnosis
 History
– Drug use, infection, illness (hepatic,
renal, cardiac), surgeries
 Laboratory
tests- serum glucose,
CBC, lytes, BUN/Cr, UA
 Other tests: ECG, CXR
Diagnosis
 Differential
– Neurologic: CVA/TIA, seizure disorder
– Drug/alcohol intoxication
– Psychosis, depression
Treatment

Glucose
– Oral glucose
– IV dextrose: 5-20% solutions, 50% ampules
– IM glucagon
Monitor glucose q 2-4 hours
 If adrenal insufficiency, administer 100 mg
hydrocortisone & 1 mg glucagon
 If resistant hypoglycemia secondary to
sulfonylureas, administer diazoxide 300
mg over 30 minutes IV q 4 hours PRN

Prevention
 Treatment
of underlying problem
– Eliminate/reduce offending drug
– Resection of insulinoma
– Treat infection
– Frequent feedings, avoidance of fasting
Related documents